Transient visual loss

International Ophthalmology Clinics

Volumn 49, Issue 3, 2009, Pages 147-166

  Thurtell, Matthew J ^a   Rucker, Janet C ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANAMNESIS; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CLINICAL EXAMINATION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; OPHTHALMOSCOPY; OPTIC NEURITIS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RETINA BLOOD VESSEL OCCLUSION; REVIEW; TRANSIENT VISUAL LOSS; TRANSITIONAL BLINDNESS; VISUAL IMPAIRMENT;

ANGIOGRAPHY; BRAIN DISEASES; CONTRAST MEDIA; CRANIOCEREBRAL TRAUMA; EYE DISEASES; HUMANS; ISCHEMIA; MIGRAINE WITH AURA; OCCIPITAL LOBE; RECOVERY OF FUNCTION; SEIZURES; TIME FACTORS; VASCULAR DISEASES; VISION DISORDERS; VISION, BINOCULAR; VISION, MONOCULAR;

EID: 68949151604     PISSN: 00208167     EISSN: None     Source Type: Journal    
DOI: 10.1097/IIO.0b013e3181a8d41f     Document Type: Review

References (86)

1. Biousse V, Trobe JD. Transient monocular visual loss. AmJ Ophthalmol. 2005;140:717-721.
2. Bruno A, Corbett JJ, Biller J, et al. Transient monocular visual loss patterns and associated vascular abnormalities. Stroke. 1990;21:34-39.
3. Donders RC, Dutch TMB Study Group. Clinical features of transient monocular blindness and the likelihood of atherosclerotic lesions of the internal carotid artery. / Neurol Neurosurg Psychiatry. 2001 ;71:247-249.
4. Russell RW. The source of retinal emboli. Lancet. 1968;2:789-792.
5. Babikian V, Wijman CA, Koleini B, et al. Retinal ischemia and embolism: etiologies and outcomes based on a prospective study. Cerebrovasc Dis. 2001;12:108-113.
6. Hoya K, Morikawa E, Tamura A, et al. Common carotid artery stenosis and amaurosis fugax.J Stroke Cerebrovasc Dis. 2008; 17:1-4.
7. Braat AE, Hoogland PH, de Vries AC, et al. Amaurosis fugax and stenosis of the ophthalmic artery: a case report. Vasc Surg. 2001;35:141-143.
8. Biousse V, Touboul PJ, D'Anglejan-Chatillon J, et al. Ophthalmologic manifestations of internal carotid artery dissection. Am J Ophthalmol. 1998;126:565-577. (Pubitemid 28475921)
9. Bolo-Deoku J Jr, Orchard RT, Fison PN. Transient loss of peripheral vision as the presentation of left atrial myxoma. Br J Ophthalmol. 1992;76:113-114.
10. Nedeltchev K, Arnold M, Wahl A, et al. Outcome of patients with cryptogenic stroke and patent foramen ovale. J Neurol Neurosurg Psychiatry. 2002;72:347-350.
11. Miller NR. Embolic causes of transient monocular visual loss. Ophthalmol Clin North Am. 1996;9:359-380.
12. Wardlaw JM, Chappell FM, Best JJ, et al. Non-invasive imaging compared with intra-arterial angiography in the diagnosis of symptomatic carotid stenosis: a meta-analysis. Lancet. 2006;367:1503-1512.
13. 13.Jabaudon D, Sztajzel J, Sievert K, et al. Usefulness of ambulatory 7-day ECG monitoring for the detection of atrial fibrillation and flutter after acute stroke and transient ischemic attack. Stroke. 2004;35:1647-1651.
14. Benavente O, Eliasziw M, Streifler JY, et al. Prognosis after transient monocular blindness associated with carotid-artery stenosis. NEngl JMed. 2001;345:1084-1090.
15. Murad MH, Flynn DN, Elamin MB, et al. Endarterectomy versus stenting for carotid artery stenosis: a systematic review and meta-analysis. J Vasc Surg. 2008;48: 487-493.
16. Park MS, Kim JT, Lee KR, et al. Recurrent transient monocular blindness with ophthalmic artery stenosis. Eur Neurol. 2008;59:202-204.
17. Nakajima M, Kimura K, Minematsu K, et al. A case of frequently recurring amaurosis fugax with atherothrombotic ophthalmic artery occlusion. Neurology. 2004;62: 117-118.
18. Furlan AJ, Whisnant JP, Kearns TP. Unilateral visual loss in bright light: an unusual symptom of carotid artery occlusive disease. Arch Neurol. 1979;36:675-676.
19. Kaiboriboon K, Piriyawat P, Selhorst JB. Light-induced amaurosis fugax. Am J Ophthalmol. 2001;131:674-676.
20. Levin LA, Mootha VV. Postprandial transient visual loss: a symptom of critical carotid stenosis. Ophthalmology. 1997;104:397-401.
21. Kofoed PK, Milea D, Larsen M. Transient monocular blindness precipitated by sexual intercourse. Br J Ophthalmol. 2008. doi:10.1136/bjo.2007.135780.
22. Mizener JB, Podhajsky P, Hayreh SS. Ocular ischemic syndrome. Ophthalmology. 1997; 104:859-864.
23. Chen CS, Miller NR. Ocular ischemic syndrome: review of clinical presentations, etiology, investigation, and management. Compr Ophthalmol Updat. 2007;8:17-28.
24. Nagurney JT, Feldman D, Cahill DP, et al. Unusual visual symptoms in a patient with bilateral vertebral artery dissection: a case report. J Emerg Med. 2006;31: 169-171.
25. Dennis MS, Bamford JM, Sandercock PA, et al. Lone bilateral blindness: a transient ischemic attack. Lancet. 1989;1:183-188.
26. Krasnianski M, Bau V, Neudecker S, et al. Isolated bilateral blindness as the sole manifestation of transient ischaemic attacks. Acta Ophthalmol Scand. 2006;84: 415-418.
27. Caplan LR, Wityk RJ, Glass TA, et al. New England Medical Center posterior circulation registry. Ann Neurol. 2004;56:389-398.
28. Savitz SI, Caplan LR. Vertebrobasilar disease. N Engl J Med. 2005;352:2618-2626.
29. Taylor CL, Selman WR, Ratcheson RA. Steal affecting the central nervous system. Neurosurgery. 2002;50:679-688.
30. Kuether TA, Nesbit GM, Clark WM, et al. Rotational vertebral artery occlusion: a mechanism of vertebrobasilar insufficiency. Neurosurgery. 1997;41:427-432.
31. Akdal G, Thurtell MJ, Halmagyi GM. Giant cell arteritis presenting with bilateral vertebral and axillary artery occlusions. Intern MedJ. 2008;38:741-742.
32. Streifler JY, Eliasziw M, Benavente OR, et al. The risk of stroke in patients with first-ever retinal versus hemispheric transient ischemic attacks and high-grade carotid stenosis. North American Symptomatic Carotid Endarterectomy Trial. Arch Neurol. 1995;52:246-249.
33. Barnett HJ, Taylor DW, Eliasziw M, et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med. 1998;339: 1415-1425.
34. Ralea IC, Nighoghossian N, Tahon F, et al. Stenting of symptomatic basilar and vertebral artery stenosis in patients resistant to optimal medical prevention: the Lyon stroke unit experience. Eur Neurol. 2008;60:127-131.
35. Glutz Von Blotzheim S, Borruat F-X. Neuro-ophthalmic complications of biopsy-proven giant cell arteritis. Eur J Ophthalmol. 1997;7:375-382.
36. Hayreh SS, Podhajsky PA, Zimmerman B. Ocular manifestations of giant cell arteritis. AmJ Ophthalmol. 1998;125:509-520. (Pubitemid 28236919)
37. Gonzalez-Gay MA, Garcia-Porrua C, Llorca J, et al. Visual manifestations of giant cell arteritis: trends and clinical spectrum in 161 patients. Medicine. 2000;79: 283-292.
38. Diego M, Margo CE. Postural vision loss in giant cell arteritis. J Neuroophthalmol. 1998;18:124-126.
39. Liozon E, Herrmann F, Ly K, et al. Risk factors for visual loss in giant cell (temporal) arteritis: a prospective study of 174 patients. Am J Med. 2001;1 11:211-217.
40. Parikh M, Miller NR, Lee AG, et al. Prevalence of a normal C-reactive protein with an elevated erythrocyte sedimentation rate in biopsy-proven giant cell arteritis. Ophthalmology. 2006;1 13:1842-1845.
41. Miller NR. Visual manifestations of temporal arteritis. Rheum Clin North Am. 2001; 27:781-797.
42. Kawasaki A, Purvin V Giant cell arteritis: an updated review. Acta Ophthalmol. 2009; 87:13-32.
43. Russell MB, Olesen J. A nosographic analysis of the migraine aura in a general population. Brain. 1996;119:355-361.
44. Headache Classification Committee of the International Headache Society. The international classification of headache disorders (second edition). Cephalalgia. 2004;24(suppl 1): 1-160.
45. Troost BT, Newton TH. Occipital lobe arteriovenous malformations: clinical and radiologic features in 26 cases with comments on differentiation from migraine. Arch Ophthalmol. 1975;93:250-256.
46. Wijman CA, Wolf PA, Kase CS, et al. Migrainous visual accompaniments are not rare in late life: the Framingham study. Stroke. 1998;29:1539-1543.
47. Fisher CM. Late-life (migrainous) scintillating zigzags without headache: one person's 27-year experience. Headache. 1999;39:391-397.
48. Bickerstaff ER. Basilar artery migraine. Lancet. 1961; 1:15-17.
49. Grosberg BM, Solomon S, Friedman DI, et al. Retinal migraine reappraised. Cephalalgia. 2006;26:1275-1286.
50. Hill DL, Daroff RB, Ducros A, et al. Most cases labeled as ''retinal migraine'' are not migraine.J Neuroophthalmol. 2007;27:3-8.
51. Kline LB, Kelly CL. Ocular migraine in a patient with cluster headaches. Headache. 1980;20:253-257.
52. Burger SK, Saul RF, Selhorst JB, et al. Transient monocular blindness caused by vasospasm. N Engl J Med. 1992;326:837-838.
53. Winterkorn JM, Kupersmith MJ, Wirtschafter JD, et al. Treatment of vasospastic amaurosis fugax with calcium-channel blockers. N Engl J Med. 1993;329:396-398.
54. Goadsby PJ. Recent advances in the diagnosis and management of migraine. BMJ. 2006;332:25-29.
55. Salanova V, Andermann F, Olivier A, et al. Occipital lobe epilepsy: electroclinical manifestations, electrocorticography, cortical stimulation and outcome in 42 patients treated between 1930 and 1991: surgery of occipital lobe epilepsy. Brain. 1992; 115: 1655-1680.
56. Panayiotopoulos CP. Elementary visual hallucinations in migraine and epilepsy. / Neurol Neurosurg Psychiatry. 1994;57:1371-1374.
57. Panayiotopoulos CP. Elementary visual hallucinations, blindness, and headache in occipital epilepsy: differentiation from migraine. J Neurol Neurosurg Psychiatry. 1999; 66:536-540.
58. Taylor I, Scheffer IE, Berkovic SF. Occipital epilepsies: identification of specific and newly recognized syndromes. Brain. 2003; 126:753-769.
59. Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med. 1996;334:494-500.
60. Casey SO, Sampaio RC, Michel E, et al. Posterior reversible encephalopathy syndrome: utility of fluid-attenuated inversion recovery MR imaging in the detection of cortical and subcortical lesions. AmJ Neuroradiol. 2000;21:1199-1206.
61. Striano P, Striano S, Tortora F, et al. Clinical spectrum and critical care management of posterior reversible encephalopathy syndrome (PRES). Med Sci Monit. 2005;11: CR549-CR553.
62. Lantos G. Cortical blindness due to osmotic disruption of the blood-brain barrier by angiographic contrast material: CT and MRI studies. Neurology. 1989;39: 567-571.
63. Saigal G, Bhatia R, Bhatia S, et al. MR findings of cortical blindness following cerebral angiography: is this entity related to posterior reversible leukoencephalopathy? AmJ Neuroradiol. 2004;25:252-256.
64. Gleeson AP, Beattie TF. Post-traumatic transient cortical blindness in children: a report of four cases and a review of the literature. J Accid Emerg Med. 1994;11: 250-252.
65. Rodriguez A, Lozano JA, del Pozo D, et al. Post-traumatic transient cortical blindness. Int Ophthamol. 1993;17:277-283.
66. Kaye EM, Herskowitz J. Transient post-traumatic cortical blindness: brief v prolonged syndromes in childhood.J Child Neurol. 1986;1:206-210.
67. Le Fort D, Safran AB, Picard F, et al. Elicited repetitive daily blindness: a new familial disorder related to migraine and epilepsy. Neurology. 2004;63:348-350.
68. Sadun AA, Currie JN, Lessell S. Transient visual obscurations with elevated optic discs. Ann Neurol. 1984; 16:489-494.
69. Lorentzen SE. Drusen of the optic disc. Dan Med Bull. 1967; 14:293-298.
70. Meyer E, Gdal-On M, Zonis S. Transient monocular blindness in a case of drusen of the optic disc. Ophthalmologica. 1973;166:321-326.
71. Auw-Haedrich C, Staubach F, Witschel H. Optic disk drusen. Surv Ophthalmol. 2002; 47:515-532.
72. Newman NJ, Lessell S, Brandt EM. Bilateral central retinal artery occlusions, disk drusen, and migraine. AmJ Ophthalmol. 1989;107:236-240.
73. Selhorst JB, Saul RF. Uhthoff and his symptom.J Neuroophthalmol. 1995; 15:63-69.
74. Otto CS, Coppit GL, Mazzoli RA, et al. Gaze-evoked amaurosis: a report of five cases. Ophthalmology. 2003;110:322-326.
75. Segal S, Salyani A, DeAngelis DD. Gaze-evoked amaurosis secondary to an intraorbital foreign body. Can J Ophthalmol. 2007;42:147-148.
76. O'Duffy D, James B, Elston J. Idiopathic intracranial hypertension presenting with gaze-evoked amaurosis. Acta Ophthalmol Scand. 1998;76:119-120.
77. Sandberg MA, Gaudio AR. Slow photostress recovery and disease severity in age-related macular degeneration. Retina. 1995;15:407-412.
78. O'Sullivan E, Shaunak S, Matthews T, et al. Transient monocular blindness.J Neurol Neurosurg Psychiatry. 1995;59:559.
79. Abe A, Nishiyama Y, Kitahara I, et al. Painless transient monocular loss of vision resulting from angle-closure glaucoma. Headache. 2007;47:1098-1099.
80. Cates CA, Newman DK. Transient monocular visual loss due to uveitis-glaucoma-hyphaema (UGH) syndrome. J Neurol Neurosurg Psychiatry. 1998;65:131-132.
81. Reed JW, Jacoby BG, Weaver RG. Corneal epithelium basement membrane dystrophy: an overlooked cause of painless visual disturbances. Ann Ophthalmol. 1992;24:471-474.
82. Tutt R, Bradley A, Begley C, et al. Optical and visual impact of tear break-up in human eyes. Invest Ophthalmol Vis Sci. 2000;41:4117-4123.
83. Smit RL, Baarsma GS, Koudstaal PJ. The source of embolism in amaurosis fugax and retinal artery occlusion. Int Ophthalmol. 1994;18:83-86.
84. Tippin J, Corbett JJ, Kerber RE, et al. Amaurosis fugax and ocular infarction in adolescents and young adults. Ann Neurol. 1989;26:69-77.
85. Hsu HY, Chao AC, Chen YY, et al. Reflux of jugular and retrobulbar venous flow in transient monocular blindness. Ann Neurol. 2008;63:247-253.
86. Winterkorn JM, Mack P, Eggenberger E. Transient visual loss in a 60-year-old man. Surv Ophthalmol. 2008;53:301-305.